Cue Biopharma Granted U.S. Patents on Lead Clinical Program Novel Drug Product Candidate CUE-101

NEXT STORY
Ehave Appoints Board-Certified Gastroenterologist And Licensed Physician Dr. Rahul Dixit To Its Medical Advisory Board
PREV STORY
Black Diamond Therapeutics and OpenEye Scientific Announce Collaboration to Expand MAP Drug Discovery Platform
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Preclinical Data for Kura Oncology Development Compounds to be Presented at AACR Annual Meeting 2017

LA JOLLA, Calif., March 29, 2017 (GLOBE NEWSWIRE) -- Kura Oncology, Inc. (Nasdaq:KURA), a ...

author_avatar
NASDAQ Market News

European CEO announces the top CEOs and companies of 2018

LONDON, Dec. 07, 2018 (GLOBE NEWSWIRE) -- Though not as tumultuous as last year, ...

author_avatar
NASDAQ Market News

Midatech Pharma US enrols first patient in Gelclair trial in stem cell transplant

8 June 2018 Midatech Pharma PLC(“Midatech”, “Company” or “Group”) Midatech Pharma US enrols first ...

author_avatar
NASDAQ Market News